Csenge Advisory Group’s ResMed RMD Stock Holding History

Csenge Advisory Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,497	Closed	-$1.08M	–	802
2025 Q4	$1.08M	Buy	+4,497	New	+$1.15M	0.05%	292
2018 Q4	–	Sell	-4	Closed	–	–	1200
2018 Q3	$0	Buy	+4	New	+$438	﹤0.01%	1507

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Csenge Advisory Group's RMD Position: Q1 2026 in Review

Csenge Advisory Group sold out of ResMed (RMD) in Q1 2026, closing a stake of 4,497 shares — an estimated $1.08M sold.

Csenge Advisory Group first reported a position in RMD in Q3 2018 and held it in 2 quarters. The position peaked at $1.08M in Q4 2025. 941 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Csenge Advisory Group reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Csenge Advisory Group sold 4,497 ResMed shares in Q1 2026, an estimated $1.08M.
Csenge Advisory Group first reported a position in ResMed in Q3 2018 and held it in 2 quarters.
Csenge Advisory Group's ResMed position peaked at $1.08M in Q4 2025.
941 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.